Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
1.570
-0.110 (-6.55%)
At close: Jul 10, 2026, 4:00 PM EDT
1.560
-0.010 (-0.64%)
After-hours: Jul 10, 2026, 7:59 PM EDT
Outlook Therapeutics Market Cap
Outlook Therapeutics has a market cap or net worth of $189.76 million as of July 10, 2026. Its market cap has increased by 146.00% in one year.
Market Cap
189.76M
Enterprise Value
209.20M
1-Year Change
146.00%
Ranking
Category
Stock Price
$1.57
Market Cap Chart
Since June 14, 2016, Outlook Therapeutics's market cap has increased from $97.37M to $189.76M, an increase of 94.89%. That is a compound annual growth rate of 6.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 189.76M | 87.32% |
| Dec 31, 2025 | 101.30M | 115.21% |
| Dec 31, 2024 | 47.07M | -54.10% |
| Dec 29, 2023 | 102.54M | -63.01% |
| Dec 30, 2022 | 277.20M | -9.11% |
| Dec 31, 2021 | 304.99M | 84.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcturus Therapeutics Holdings | 198.11M |
| Protalix BioTherapeutics | 196.59M |
| Caribou Biosciences | 190.92M |
| Q32 Bio | 190.08M |
| Acumen Pharmaceuticals | 189.96M |
| Tenaya Therapeutics | 188.88M |
| Humacyte | 187.05M |
| Equillium | 183.99M |